All News

To better understand the implications of the expanded approval and the potential for Opdivo, we spoke to Jedd D. Wolchok from Memorial Sloan Kettering Cancer Center.

A breast cancer and melanoma survivor ponders her relationship with her body several years after diagnoses.

The designation is based on data from the phase 2 TOPARP-A trial that demonstrated that Lynparza monotherapy had an overall response rate of nearly 90 percent in a biomarker-defined subgroup of patients who had DNA-repair defects.

Cancer and the blues go together like chemotherapy and hair loss.

Living through illness is never easy. It is so tempting to let diseases and diagnoses take our energy and make us bystanders in our own lives. But if every day of our life — even when full of suffering — is an adventure to be lived, how can we be a part of it? Because we must be a part of it.

"Our latest study is the first to demonstrate that blocking or deleting the A2A receptor can be useful in reducing radiation-induced scarring in skin," Bruce Cronstein said.

These data were presented in mid-December 2015.

The study was stopped early after an independent monitoring panel determined the primary endpoint of improvement in OS was met.

A legendary cornerback in the NFL, former New England Patriots and Los Angeles Raiders star Mike Haynes is no stranger to going to battle on the gridiron.

Following doctors orders is what we're supposed to do, but sometimes it's a personal choice.

The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study.

Despite the fact that it has been three years since the drug was approved by the FDA, many oncologists still need to be educated regarding Xofigo's benefits beyond pain palliation,

A breast cancer and melanoma survivor reflects on being tired of her cancers and living with uncertainty.

Results from new clinical trials signal a role for the immunotherapy Opdivo in the treatment of gastric cancer and heavily pretreated esophageal cancer.

Exercise, protein, belief and visualization are my not-so-secret weapons in my life with metastatic breast cancer.

How I use the law of attraction to take back control of my mental, emotional and spiritual health.

To gain insight into the methodology and impacts of this research, CURE interviewed Joan H. Schiller, an author on the study.

This study of Onivyde, 5-FU and leucovorin for the treatment of patients with metastatic pancreatic cancer was presented at the 2016 Gastrointestinal Cancers Symposium.

"Response rate and survival were similar to historical controls, and the primary endpoint was not met," said lead investigator Matthew Galsky.

The approval was based on data from the phase 3 CheckMate-067 trial.

"We've shown for the first time that an alternative to standard chemoradiation is well tolerated with lower acute toxicity," said co-author Lucjan Wyrwicz.

When the question “Why did I get cancer?” becomes “Why did I survive cancer, while others did not?” the guilt reflex is turned on its head.

A male breast cancer survivor shares his humorous twist to health and healing.

I have filed for divorce from my relationship with fear. Cancer fears have been a part of my life for over five years and I think the relationship has simply run its course.

A cancer survivor wonders if chemicals contributed to her breast cancer or melanoma.

Cancer benched me, but it's time to feel alive again and remember that I am much more than a person who is recovering from a disease.

Shannon Kerr isn't shy about proclaiming her status as a cancer survivor. At the 2016 Battlefrog Fiesta Bowl in Phoenix, Kerr was joined by a stadium full of fans in drawing attention to the disease and the toll it can take.

In an interview with CURE, Anees B. Chagpar, from The Breast Center at Smilow Cancer Hospital at Yale-New Haven, shares her thoughts on the final guidelines and how they change the focus of screening.